Each mL contains:

Active ingredient: erythromycin – 20 mg

For the full list of excipients, see section List of excipients.

Adults and adolescents

To be applied in a thin film to the affected area twice daily after washing and drying the skin. Hands should be washed after application.

Patients should be advised that a therapeutic effect may not be seen until after 6-8 weeks of treatment. Treatment may be continued for up to a maximum of 6 months. If there has been no improvement after 6 to 8 weeks, or if the condition becomes worse, treatment should be discontinued.

Owing to the flammable nature of the product, Erythromycin solution should be kept away from open fire and flames and all sources of ignition, including smoking, during and immediately after use.

Paediatric population

Safety and effectiveness of topical erythromycin in children under the age of 12 have not been established.

Elderly

There are no specific recommendations for use in the elderly.

Renal impairment

No dosage adjustment is necessary.

Hepatic impairment

No dosage adjustment is necessary.

Pharmacotherapeutic group: Erythromycin,

ATC code: D10AF02

List of excipients

Propylene Glycol

Ethanol.

For more detailed information about the drug, click: http://pharm.cals.am/pharm/data/drug_134482/1734095746965.pdf